If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email firstname.lastname@example.org.
Please tell us what format you need. It will help us if you say what assistive technology you use.
This guidance helps local authorities and NHS England to respond to NPS use and problems. NPS includes mephedrone, 2-DPMP and some synthetic cannabinoids that are often called ‘spice’.
The guidance covers a range of important areas:
monitoring and sharing information
responding to acute NPS problems
Interventions and treatment include:
staff competence to deal with NPS problems
tackling NPS in prisons
This guidance was produced in consultation with commissioners and other relevant professionals.